• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IB1期宫颈癌患者盆腔淋巴结转移的区域特异性危险因素

Region-specific Risk Factors for Pelvic Lymph Node Metastasis in Patients with Stage IB1 Cervical Cancer.

作者信息

Zhao Jing, Cai Jing, Wang Hongbo, Dong Weihong, Zhang Yuan, Wang Shaohai, He Xiaoqi, Sun Si, Huang Yuhui, Huang Bangxing, Willborn Kay C, Jiang Ping, Wang Zehua

机构信息

Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

出版信息

J Cancer. 2021 Mar 5;12(9):2624-2632. doi: 10.7150/jca.53215. eCollection 2021.

DOI:10.7150/jca.53215
PMID:33854622
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8040729/
Abstract

We aimed to identify the risk factors associated with pelvic lymph node metastasis (LNM) at each anatomic location in patients with stage IB1 cervical cancer. A primary cohort of 728 patients with stage IB1 cervical cancer who underwent radical hysterectomy and systematic pelvic lymphadenectomy were retrospectively studied. All removed pelvic nodes (=20,134) were pathologically examined. The risk factors for LNM in different anatomic regions (obturator, internal iliac, external iliac, and common iliac) were evaluated by multivariate logistic regression analyses. Nomograms were generated from the primary cohort and validated in another external cohort =242). The performance of the nomogram was assessed by its calibration and discrimination. Overall survival and progression-free survival in patients with different LNM patterns were compared. : LNM was found in 266 (1.3%) removed nodes and 106 (14.6%) patients. The incidences of LNM at the obturator, internal iliac, external iliac, common iliac, and parametrial regions were 8.5%, 5.4%, 4.7%, 1.9% and 1.8%, respectively. Among others, tumour size and lymph-vascular space invasion (LVSI), which are preoperatively assessable, were identified as independent risk factors of LNM in the common iliac region and the lower pelvis, respectively, and age was an additional independent risk factor of obturator LNM. The negative predictive values of tumour size <2 cm for common iliac LNM and negative LVSI combined with older age (> 50 years) for obturator LNM were 100% and 98.7%, respectively. A nomogram of these two factors showed good calibration and discrimination (concordance index, 0.761 in the primary cohort and 0.830 in validation cohort). The patients with common iliac LNM had poorer survival than those with LNM confined to the lower pelvis, while the differences in survival between patients with LNM confined to one node, one region or single side and those with more widely spreading LNM were not statistically significant. Tumour size, LVSI and age are region-specific risk factors for pelvic LNM in IB1 cervical cancer, which could be used to allocate the appropriate extent of pelvic lymphadenectomy.

摘要

我们旨在确定IB1期宫颈癌患者盆腔各解剖部位发生盆腔淋巴结转移(LNM)的相关危险因素。对728例行根治性子宫切除术和系统性盆腔淋巴结清扫术的IB1期宫颈癌患者的原始队列进行了回顾性研究。对所有切除的盆腔淋巴结(共20134个)进行了病理检查。通过多因素逻辑回归分析评估不同解剖区域(闭孔、髂内、髂外和髂总)LNM的危险因素。根据原始队列生成列线图,并在另一个外部队列(n = 242)中进行验证。通过校准和鉴别评估列线图的性能。比较了不同LNM模式患者的总生存期和无进展生存期。结果显示:在切除的淋巴结中有266个(1.3%)发现LNM,106例(14.6%)患者发生LNM。闭孔、髂内、髂外、髂总和宫旁区域LNM的发生率分别为8.5%、5.4%、4.7%、1.9%和1.8%。其中,术前可评估的肿瘤大小和淋巴血管间隙浸润(LVSI)分别被确定为髂总区域和骨盆下部LNM的独立危险因素,年龄是闭孔LNM的另一个独立危险因素。肿瘤大小<2 cm对髂总LNM的阴性预测值以及LVSI阴性联合年龄较大(>50岁)对闭孔LNM的阴性预测值分别为100%和98.7%。这两个因素的列线图显示出良好的校准和鉴别能力(一致性指数,原始队列中为0.761,验证队列中为0.830)。髂总LNM患者的生存期比LNM局限于骨盆下部的患者差,而LNM局限于一个淋巴结、一个区域或单侧的患者与LNM广泛扩散的患者之间的生存差异无统计学意义。肿瘤大小、LVSI和年龄是IB1期宫颈癌盆腔LNM的区域特异性危险因素,可用于确定盆腔淋巴结清扫术的合适范围。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cff7/8040729/232ab696c52e/jcav12p2624g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cff7/8040729/64b3b1f0587c/jcav12p2624g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cff7/8040729/d997640bdd14/jcav12p2624g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cff7/8040729/232ab696c52e/jcav12p2624g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cff7/8040729/64b3b1f0587c/jcav12p2624g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cff7/8040729/d997640bdd14/jcav12p2624g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cff7/8040729/232ab696c52e/jcav12p2624g003.jpg

相似文献

1
Region-specific Risk Factors for Pelvic Lymph Node Metastasis in Patients with Stage IB1 Cervical Cancer.IB1期宫颈癌患者盆腔淋巴结转移的区域特异性危险因素
J Cancer. 2021 Mar 5;12(9):2624-2632. doi: 10.7150/jca.53215. eCollection 2021.
2
Number of Removed Pelvic Lymph Nodes as a Prognostic Marker in FIGO Stage IB1 Cervical Cancer with Negative Lymph Nodes.切除的盆腔淋巴结数目作为 FIGO 期 IB1 淋巴结阴性宫颈癌的预后标志物。
J Minim Invasive Gynecol. 2020 May-Jun;27(4):946-952. doi: 10.1016/j.jmig.2019.08.002. Epub 2019 Aug 5.
3
Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.接受根治性子宫切除术和系统性腹膜后淋巴结清扫术治疗的浸润性宫颈癌组织病理学预后因素的多变量分析。
Acta Obstet Gynecol Scand. 2002 Dec;81(12):1144-51. doi: 10.1034/j.1600-0412.2002.811208.x.
4
Predictive Factors of Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer.早期宫颈癌盆腔淋巴结转移的预测因素。
Oncol Res Treat. 2018;41(4):194-198. doi: 10.1159/000485840. Epub 2018 Mar 23.
5
Retrospective analysis of the incidence and predictive factors of parametrial involvement in FIGO IB1 cervical cancer.回顾性分析 FIGO IB1 期宫颈癌中宫旁浸润的发生率及预测因素。
J Gynecol Obstet Hum Reprod. 2021 Oct;50(8):102145. doi: 10.1016/j.jogoh.2021.102145. Epub 2021 Apr 10.
6
[The rule of metastatic pelvic lymph node distribution in patients with early stage cervical carcinoma].[早期宫颈癌患者盆腔转移性淋巴结分布规律]
Zhonghua Zhong Liu Za Zhi. 2008 Jun;30(6):452-5.
7
[Incidence and influencing factors of distal external iliac lymph node metastasis in early cervical cancer].[早期宫颈癌髂外淋巴结远端转移的发生率及影响因素]
Zhonghua Zhong Liu Za Zhi. 2014 Jun;36(6):457-60.
8
The Number of Positive Pelvic Lymph Nodes and Multiple Groups of Pelvic Lymph Node Metastasis Influence Prognosis in Stage IA-IIB Cervical Squamous Cell Carcinoma.阳性盆腔淋巴结数量及多组盆腔淋巴结转移对IA-IIB期宫颈鳞状细胞癌预后的影响
Chin Med J (Engl). 2015 Aug 5;128(15):2084-9. doi: 10.4103/0366-6999.161372.
9
Can pelvic lymphadenectomy be omitted in patients with stage IA2, IB1, and IIA1 squamous cell cervical cancer?IA2期、IB1期和IIA1期宫颈鳞状细胞癌患者能否省略盆腔淋巴结清扫术?
Springerplus. 2016 Aug 5;5(1):1262. doi: 10.1186/s40064-016-2927-5. eCollection 2016.
10
Preoperative prediction of retroperitoneal lymph node involvement in clinical stage IB and IIA cervical cancer.临床ⅠB期和ⅡA期宫颈癌患者腹膜后淋巴结转移的术前预测
J Cancer Res Ther. 2022 Oct-Dec;18(6):1548-1552. doi: 10.4103/jcrt.JCRT_106_20.

引用本文的文献

1
Development and validation of a risk prediction model for lymph node metastasis in stage IA2-IIA1 cervical cancer based on laboratory parameters.基于实验室参数的IA2-IIA1期宫颈癌淋巴结转移风险预测模型的建立与验证
Am J Cancer Res. 2025 Mar 15;15(3):1081-1095. doi: 10.62347/EOXM6715. eCollection 2025.
2
A Multicenter Study on the Relationship of Tumor Lesion Location with Bilateral Parametrial Involvement and Pelvic Lymph Node Metastasis in Cervical Squamous Cell Carcinoma.一项关于宫颈鳞状细胞癌肿瘤病变位置与双侧宫旁受累及盆腔淋巴结转移关系的多中心研究。
Ann Surg Oncol. 2025 May;32(5):3449-3457. doi: 10.1245/s10434-024-16802-8. Epub 2025 Jan 25.
3

本文引用的文献

1
Multiparametric MRI-Based Radiomics Nomogram for Predicting Lymph Node Metastasis in Early-Stage Cervical Cancer.基于多参数磁共振成像的影像组学列线图预测早期宫颈癌淋巴结转移
J Magn Reson Imaging. 2020 Sep;52(3):885-896. doi: 10.1002/jmri.27101. Epub 2020 Feb 25.
2
Risk factors for failure of bilateral sentinel lymph node mapping in early-stage cervical cancer.早期宫颈癌双侧前哨淋巴结定位失败的危险因素。
Gynecol Oncol. 2020 Jan;156(1):93-99. doi: 10.1016/j.ygyno.2019.10.027. Epub 2019 Dec 12.
3
Diagnostic performance of MR imaging in evaluating prognostic factors in patients with cervical cancer: a meta-analysis.
Predictors of Non-Sentinel Lymph Node Metastasis in Patients with Positive Sentinel Lymph Node in Early-Stage Cervical Cancer: A SENTICOL GROUP Study.
早期宫颈癌前哨淋巴结阳性患者非前哨淋巴结转移的预测因素:一项SENTICOL组研究
Cancers (Basel). 2023 Sep 26;15(19):4737. doi: 10.3390/cancers15194737.
4
MRI radiomics combined with clinicopathologic features to predict disease-free survival in patients with early-stage cervical cancer.MRI 放射组学结合临床病理特征预测早期宫颈癌患者无病生存。
Br J Radiol. 2022 Aug 1;95(1136):20211229. doi: 10.1259/bjr.20211229. Epub 2022 May 30.
5
Risk Factor Assessment of Lymph Node Metastasis in Patients With FIGO Stage IB1 Cervical Cancer.国际妇产科联盟(FIGO)IB1期宫颈癌患者淋巴结转移的危险因素评估
Front Oncol. 2022 Mar 30;12:809159. doi: 10.3389/fonc.2022.809159. eCollection 2022.
6
Data from small cell neuroendocrine carcinoma of the cervix: FIGO 2018 staging is more accurate than FIGO 2009.来源于宫颈小细胞神经内分泌癌的数据:FIGO 2018 分期比 FIGO 2009 更准确。
J Int Med Res. 2022 Jan;50(1):3000605211067397. doi: 10.1177/03000605211067397.
7
Can Conization Specimens Predict Sentinel Lymph Node Status in Early-Stage Cervical Cancer? A SENTICOL Group Study.宫颈锥切标本能否预测早期宫颈癌前哨淋巴结状态?SENTICOL 组研究。
Cancers (Basel). 2021 Oct 29;13(21):5423. doi: 10.3390/cancers13215423.
8
FABP4 is an independent risk factor for lymph node metastasis and poor prognosis in patients with cervical cancer.脂肪酸结合蛋白4(FABP4)是宫颈癌患者发生淋巴结转移和预后不良的独立危险因素。
Cancer Cell Int. 2021 Oct 26;21(1):568. doi: 10.1186/s12935-021-02273-4.
磁共振成像在评估宫颈癌患者预后因素中的诊断性能:一项荟萃分析。
Eur Radiol. 2020 Mar;30(3):1405-1418. doi: 10.1007/s00330-019-06461-9. Epub 2019 Nov 27.
4
Surgical resection based on ontogenetic cancer field theory for cervical cancer: mature results from a single-centre, prospective, observational, cohort study.基于胚胎发育性癌场理论的宫颈癌外科切除术:单中心前瞻性观察队列研究的成熟结果。
Lancet Oncol. 2019 Sep;20(9):1316-1326. doi: 10.1016/S1470-2045(19)30389-4. Epub 2019 Aug 2.
5
Scale-up of radiotherapy for cervical cancer in the era of human papillomavirus vaccination in low-income and middle-income countries: a model-based analysis of need and economic impact.在低收入和中等收入国家普及人乳头瘤病毒疫苗时代宫颈癌放射治疗的推广:基于模型的需求和经济影响分析。
Lancet Oncol. 2019 Jul;20(7):915-923. doi: 10.1016/S1470-2045(19)30308-0. Epub 2019 May 28.
6
Where Are We Going with Sentinel Lymph Node Mapping in Gynecologic Cancers?前哨淋巴结活检在妇科恶性肿瘤中的应用进展
Curr Oncol Rep. 2018 Nov 13;20(12):96. doi: 10.1007/s11912-018-0744-4.
7
Risk factors for lymphatic complications following lymphadenectomy in patients with cervical cancer.宫颈癌患者淋巴结清扫术后淋巴并发症的危险因素。
Jpn J Clin Oncol. 2018 Dec 1;48(12):1036-1040. doi: 10.1093/jjco/hyy151.
8
ESGO Survey on Current Practice in the Management of Cervical Cancer.ESGO 关于宫颈癌管理现状的调查。
Int J Gynecol Cancer. 2018 Jul;28(6):1226-1231. doi: 10.1097/IGC.0000000000001314.
9
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
10
Value of Intraoperative Cytological and Pathological Sentinel Lymph Node Diagnosis in Fertility-Sparing Trachelectomy for Early-Stage Cervical Cancer.术中细胞学和病理前哨淋巴结诊断在早期宫颈癌保留生育功能的气管切除术中的价值
Oncology. 2018;94(2):92-98. doi: 10.1159/000484049. Epub 2017 Nov 15.